Usefulness of Blood Biomarkers for Overall Survival in NSCLC

CompletedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

March 31, 2014

Conditions
Non-small Cell Lung Cancer
Interventions
OTHER

Blood samples

Blood samples, that were collected, processed and stored in the Maastro biobank in a standardized way, will be used to measure CRP, LDH, Osteopontin, CA-9 IL-6, IL-8, CEA, CYFRA 21-1, and α-2M. Clinical data will be retrieved from the electronic medical files.

Trial Locations (1)

6229 ET

MAASTRO clinic, Maastricht

All Listed Sponsors
lead

Maastricht Radiation Oncology

OTHER

NCT01936571 - Usefulness of Blood Biomarkers for Overall Survival in NSCLC | Biotech Hunter | Biotech Hunter